Denovo Biopharma Is A Clinical Stage Biopharmaceutical Company Focused On Developing Biomarker Driven Precision Medicinesthe Company Utilizes Its Innovative Technology Platform To Discover And Apply Biomarkers For Drug Development In Various Therapeutic Areasincluding Oncologyneurologymetabolic Diseasescardiologyand Immunology The Core Service Of Denovo Biopharma Is Its Biomarker Discovery Platformwhich Analyzes Archived Clinical Samples To Identify Genomic Biomarkers That Correlate With Patient Responses To Drug Candidatesthis Approach Enhances The Efficacy Of Late Stage Drugs And Reduces Adverse Effects By Enabling Targeted Clinical Trialsdenovo Biopharma Has A Pipeline Of First In Class Drugsincluding Db104Liafensinefor Treatment Resistant Depressiondb108 For Non Small Cell Lung Cancerand Other Investigational Drugsthe Company Operates Globallyaiming To Personalize Drug Development For Improved Patient Outcomes
United States
